Porphyria

Porphyria
ICD-10	E80.0-E80.2
ICD-9	277.1
MedlinePlus	001208
MeSH	C17.800.849.617

For patient information click here

Porphyria Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Porphyria from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Porphyria On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Porphyria All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Porphyria
CDC on Porphyria
Porphyria in the news
Blogs on Porphyria
Directions to Hospitals Treating Porphyria
Risk calculators and risk factors for Porphyria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords:Acute intermittent porphyria; hereditary coproporphyria; congenital erythropoietic porphyria; erythropoietic protoporphyria

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Porphyria is considered an absolute contraindication to the use of the following medications:

• Butalbital

Acknowledgements

Source of Initial Content: Resident report notes prepared by Duane S. Pinto, M.D. and Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]

Template:WikiDoc Sources